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One prominent immunoregulatory function of galectin-1 (Gal-1), a p-galactoside binding mammalian 
lectin, is induction of apoptosis in activated T-cells by a process depending on the activity of Src family 
tyrosine kinase, Lck. Although the requirement for Lck in Gal-1 induced T-cell death and the ability of 
Gal-1 to affect the membrane localization of extracellular Gal-1-binding proteins have been well docu­
mented, the consequence of the complex and related reorganization of extra- and intracellular signaling 
components upon Gal-1 treatment of T-cells has not yet been revealed. Therefore, we have analyzed the 
plasma membrane movement of Lck upon Gal-1 triggered signaling, and the significance of this event in 
Gal-1 induced T-cell death. Non-receptor tyrosine kinase, Lck primarily localized in the synapse of tumor 
cell-T-cell during 15 min of the established direct cell contact. Later, after 30 min, a lateral segregation of 
Lck from the cell synapse was observed. The migration of Lck to the opposite of the cell contact apparently 
depended on the expression and cell surface presentation of Gal-1 on the effector (tumor) cells and was 
accompanied by phosphorylation on the negative regulatory tyrosine residue, Tyr505. Receptor tyrosine 
phosphatase, CD45 played crucial role in this event since CD45 deficiency or inhibition of its phosphatase 
activity resulted in the failure of Lck membrane movement. Level of the Gal-1-binding glycolipid GM1 
ganglioside also essentially regulated Lck localization. Segregation of Lck and Gal-1 induced apoptosis 
was diminished in T-cells with low GM1 expression compared to T-cells with high GM1. Our results 
show that spatial regulation of Lck by CD45 and GM1 ganglioside determines the outcome of apoptotic 
response to Gal-1 and this local regulation may occur only upon intimate effector (Gal-1 expressing) 
cell-T-cell attachment.
© 2013 Elsevier Ltd. All rights reserved.
1. Introduction
T-cells and antigen presenting cells form immunological 
synapses, which are considered to assemble from specific m em ­
brane microdomains, rafts (Bromley et al., 2001; Dykstra et al., 
2001), composed of T-cell receptor (TCR), co-receptors and adhe­
sion molecules in a specific lipid environment, and scaffolded 
by the actin cytoskeleton (Burkhardt et al., 2008). The composi­
tion of membrane rafts varies during different differentiation and 
activation phases of T-cells, e.g. the amount of GM1 ganglioside
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is expressed at higher levels in effector cells, compared to res­
ting T-cells (Tuosto et al., 2001). Regulation of GM1 expression is 
substantial, as alteration in lipid raft composition may lead to inap­
propriate T lymphocyte signaling and ultim ately to development 
of pathological conditions (Jury et al., 2004). In resting T-cells, TCR 
and tyrosine kinases Lck and ZAP-70 are excluded from or weakly 
associated with rafts, however, they translocate into raft domains 
after TCR engagement (Montixi et al., 1998). Localization of acti­
vated Lck to rafts is important for the initial signaling which drives 
subsequent activation of signaling proteins, cytoskeletal changes, 
membrane remodeling and formation of stable signaling com ­
plexes at TCR activation sites (Salmond et al., 2009). Activity of Lck 
is regulated by phosphorylation of two conserved tyrosine residues, 
Tyr505 and Tyr394. Phosphorylation at Tyr505 results in a closed, 
enzymatically inactive conformation. W hen outside of the rafts, Lck 
is dephosphorylated by CD45 receptor tyrosine phosphatase at the 
Tyr-505, thereby it is potentiated for activation and autophospho­
rylation at the Tyr394 (Sieh et al., 1993; Rodgers and Rose, 1996). In 
turn, when the active Lck is recruited to adaptor Cbp/PAG in rafts,
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Csk kinase phosphorylates the negative regulatory Tyr505 of Lck 
(Kawabuchi et al., 2000) resulting in inactivation, hence terminat­
ing the activation process.
TCR clustering at the immune synapse is negatively regulated 
by particular members of the galectin family, P-galactoside binding 
lectins, which interact with cell surface glycoproteins and glycol- 
ipids and form lattice, thereby restricting glycoprotein movement 
in the cell membrane and inhibiting reorganization of signaling 
complexes (Grigorian et al., 2009). Accordingly, soluble Gal-1 bind­
ing to T-cells induces reorganization of Gal-1 binding receptors, 
and as a result CD45 and CD3 are co-localized on large islands of 
apoptotic blebs and CD7 and CD43 are co-localized in small patches 
(Pace et al., 1999). Specific membrane microdomain structure is 
crucial during Gal-1 induced T-cell apoptosis, since disruption of 
rafts results in failure of execution of Gal-1 signaling and induc­
tion of cell-death (Ion et al., 2006; Kovács-Sólyom et al., 2010). This 
apoptotic process is characterized by early tyrosine phosphoryla­
tion with involvement of tyrosine kinase, Lck, followed by ceramide 
production by acid sphingomyelinase, mitochondrial depolariza­
tion, caspase-9 and -3 activation (Ion et al., 2005, 2006).
Gal-1 is often upregulated in tumor cells and the surrounding 
stroma and it is supposed to contribute to tumor immune privilege 
(Rubinstein et al., 2004). W e have recently shown that the Gal-1 
produced by and bound to the surface of tumor cells induces cell 
death in Jurkat cells or PHA activated human peripheral blood T- 
cells in an ex vivo co-culture system (Kovács-Sólyom et al., 2010). 
This system resembles better the in vivo milieu than usage of sol­
uble protein, as lymphocytes encounter Gal-1 attached to the cell 
surface of the producer cells or components of the extracellular 
matrix (He and Baum, 2004). In this work we analyze the plasma 
membrane movements of Lck, a major component of Gal-1 trig­
gered apoptotic signaling. W e show that the membrane localization 
of Lck is affected by CD45, GM1 ganglioside and intact raft orga­
nization. Most importantly, we provide a novel insight into those 
membrane proximal events which eventually lead to T-cell apo­
ptosis.
2. Materials and methods
2.1. Cells
All cell lines were kept in an incubator with 5% CO2 at 37 °C. 
Jurkat cell lines and the CD45 deficient Jurkat variant, J45.01 
(European Collection of Cell Cultures) were cultured in RPMl- 
1640 (Gibco, Invitrogen) supplemented with penicillin (100 lU/ml), 
streptomycin (100 |ag/ml), L-glutamine (2 mM) and in the presence 
of 5% (Jurkat) or 10% (J45.01) heat inactivated fetal calf serum (FCS) 
(Gibco, Invitrogen). C32 human melanoma cells and mock trans­
fected (HeLamock) or Gal-1 transgenic (HeLaGal-1) human cervix 
adenocarcinoma cells were cultured in MEM (Gibco, lnvitrogen) 
supplemented with penicillin, streptomycin, L-glutamine and 5% 
(C32) or 10% (HeLa) FCS. Peripheral blood mononuclear (PBM) cells 
from healthy human donors were isolated through Ficoll gradient 
(GE Healthcare) and activated with 5 |ag/ml phytohemagglutinin- 
M (PHA, Calbiochem) for 72 h in RPMl containing 10% FCS. Studies 
involving human blood samples were conducted in accordance 
with the guidelines of the Declaration of Helsinki and have been 
approved by the institutional ethics committee of the University of 
Szeged.
To separate cells based on their GM1 ganglioside expression 
Jurkat or human activated T-cells were washed and resuspended 
in DMEM at 107 cells/ml, and then 20 |ag/ml cholera toxin B sub­
unit (CTX)-biotin (Sigma) was added. After 15 min incubation on 
ice the cells were washed with DMEM and 50 |al BD IM a g ™  Strep- 
tavidin Particles Plus - DM (BD Bioscience) was added to 107 cells
for 30 min at 4 °C. The cell concentration was set to 107 cells/ml 
and the tube was placed into the magnet (BD IM a q ™  cell sepa­
ration magnet) for 8 min. The negative fraction (supernatant) and 
the positive fraction (pellet) were separately cultured, and tested 
for the expression of GM1 by flow cytometry. Cells from negative 
fraction expressing low level of GM1 were designated a sJ.G M 1 lci 
and GM 1lci T-cells for Jurkat and human activated T-cells, respec­
tively. Activated T-cells with high GM1 expression were referred as 
GM 1hl T-cells. J.G M 1 lo cells were maintained in RPM I1640 with 5% 
FCS and tested for their GM1 expression before use by flow cytom e­
try. Separated human T-cells were used im mediately for apoptosis 
tests.
2.2. Flow cytometry
GM1 detection. The cells were washed in ice cold phosphate 
buffered saline (PBS) supplemented with 1% FCS and 0.1% sodium- 
azide (FACS-buffer) and resuspended at 2 x 106 cells/ml, and then 
CTX-FITC was added at a concentration of 10 |ag/ml. After incuba­
tion for 30 min on ice the samples were washed with FACS-buffer, 
and measured on FACSCalibur flow cytometer using CellQ uest™  
software (Becton & Dickinson).
Detection of surface Gal-1. HeLamock cells were treated with 
50 |ag/ml recombinant Gal-1 (rGal-1), then unbound lectin was 
removed with washing with FACS-buffer. Amount of surface Gal-1 
on Gal-1-treated HeLamock and transgenic HeLaGal-1 cells was ana­
lyzed by FITC conjugated anti-Gal-1 mAb (clone 2c1/6, produced 
in our laboratory, Kovács-Sólyom et al., 2010) and cytofluorimetry 
was carried out as described above.
2.3. Co-cultures of T-cells and Gal-1 producing tumor cells
C32 (104 cells/sample) or HeLamock and HeLaGal-1 cells 
(5 x 103 cells/sample) were plated onto round cover slips (12 mm 
diameter, Menzel Gläser, Thermo Scientific) in 24-well plate. 
Jurkat, J.G M 1 lci, J45.01 or GM 1lci and GM 1hi activated human 
T-cells (2-5 x 105 cells/sample) were labeled with Hoechst 33342 
(100 ng/ml for 30 min at 37 °C) and co-cultured with tumor cells 
for the indicated time points. In particular experiments Jurkat 
cells were incubated with the following inhibitors before added 
to tumor cells: ß-cyclodextrin (ß-CD) for raft disruption (10 mM, 
30 min, Sigma) or PTP CD45 inhibitor (10 |aM, 20 min, Santa Cruz 
Biotechnology). These inhibitors were present throughout the 
experiments.
For competing galectin binding to cell surface HeLamock and 
HeLaGal-1 cells were incubated with 100 mM lactose (Sigma) for 
30m in at 4 °C in cell culture medium, and then galectins were 
removed with extensive washing before co-culture. 50 |ag/ml 
human recombinant Gal-1 was added to indicated samples of lac­
tose washed HeLamock cells for 30 min at 4 °C and then the unbound 
Gal-1 was removed with washing before co-culture.
2.4. Immunocytochemistry
T-cells and tumor cells were co-cultured for the indicated time 
points (ranging from 15 min to 1 h), then fixed in 4% paraformalde­
hyde for 4 min at room temperature, washed in PBS and the 
cover slips were saturated in FACS-buffer for 1 h prior im muno- 
staining. The following antibodies were used: unlabeled or FITC 
conjugated mouse anti-Lck mAb (produced in our laboratory, Ion 
et al., 2005), PE conjugated mouse anti-LCK pTyr505 (B D ™  Phos- 
flow), 4G10 anti-phosphotyrosine mAb (Upstate Biotechnology, 
Millipore), unlabeled or FITC conjugated anti-Gal-1 mAb (clone 
2c1/6, produced in our laboratory, Kovács-Sólyom et al., 2010). 
Cell surface staining was carried out in FACS-buffer. For intracel­
lular staining the antibodies were added to the cells in FACS-buffer
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containing 75 |ag/ml L-(a)-lysophosphatidylcholine (LPC, Sigma), 
that rapidly permeabilize the cell membrane while retains cells’ 
integrity (Chitu et al., 1999). Unlabeled primary antibodies were 
followed by anti-mouse IgG-NorthernLights-557 (R&D Systems). To 
visualize the cell-cell contact, F-actin was labeled with Rhodamine- 
Phalloidin (Invitrogen). The cover slips were mounted on slides 
with a drop of Fluoromount-G (SouthernBiotech). The samples 
were analyzed with Axioskop 2Mot (Carl Zeiss) fluorescence micro­
scope using 40x objective magnification, or confocal images were 
taken with Olympus FV 1000 laser scanning confocal microscope, 
60x objective and zoom function. The correct exposure was deter­
mined based on the intensity plots generated by FV10-ASW 2.0 
Viewer software (Olympus) (Supplementary Fig. 1). Photos were 
taken from 10 randomly selected non-overlapping fields of the 
samples, and at least 100 cells/sample were analyzed. Localization 
of Lck in the cell-cell contact or in membrane domains opposite to 
cell-cell contact (sequestered) were determined from non-adjusted 
raw pictures and evaluated by the following equation: percentage 
of cells with the Lck sequestered or in cell contact = number o fT - 
cells with Lck sequestered or in cell contact/number of T-cells in 
contact with tumor cells) x 100. To determine the relative effect of 
Gal-1, the percentages of cells with sequestered Lck in samples with 
HeLamock were subtracted from results with HeLaGal-1. For presen­
tation of the images, the contrast of the images was adjusted using 
Adobe Photoshop CS4 extended 11.0 (Supplementary Fig. 1).
2.5. Detection of apoptosis in co-culture system
After 16 h of co-culture the cells were fixed in 4% paraformalde­
hyde for 4 min at room temperature and labeled for phos- 
phatidylserine exposure on the outer cell membrane as described 
previously (Kovács-Sólyom et al., 2010). The samples were ana­
lyzed with Axioskop 2Mot (Carl Zeiss) fluorescence microscope 
using AxioCam camera, AxioVision 3.1 software and 20 x objective 
magnification. The contrasts of the images were adjusted using 
Adobe Photoshop CS4 extended 11.0. At least 100 cells/sample were 
analyzed and the rate of apoptosis was determined as follows: % of 
apoptotic cells = (Annexin V  positive cells/total cell number) x 100.
The active (cleaved) form of caspase-3 was detected after 
24 h of T-cell/tumor cell co-culture. The cells were fixed in 4% 
paraformaldehyde for 25 min at room temperature and perme- 
abilized with 0.1% Triton X-100 in FACS-buffer for 10 min, then 
saturated in FACS-buffer for 1 h. The samples were reacted with 
rabbit anti-caspase-3 (Cell Signaling Technology) and anti- rabbit 
Ig-FITC (Sigma). After washing the cover slips were mounted on 
slides with a drop of Fluoromount-G and analyzed with Axioskop 
2Mot fluorescence microscope.
2.6. Statistics
Average and standard deviation were determined with 
Microsoft EXCEL software from the results of 3-5  independent 
samples, as indicated in figure legends. Statistical significance of 
the differences was determined using the Student’s t test (set at 
*p<0.05, **p<0.01, ***p<0.001).
3. Results
3.1. Cell-derived galectin-1 induces exclusion of Lck from cell 
synapse
W e have recently shown that stimulation ofT-cells with soluble 
recombinant Gal-1 induced remarkable tyrosine phosphorylation 
with the involvement of Lck non-receptor tyrosine kinase lead­
ing eventually to apoptosis (Ion et al., 2005, 2006). Lack of Lck in
Jurkat derivative cell line, J.CaM1.6 rendered these T-cells resis­
tant to Gal-1 induced cell death (Ion et al., 2006). Similarly, tumor 
cell-derived Gal-1 also induced T-cell death on an Lck dependent 
fashion (Kovács-Sólyom et al., 2010). The central role of Lck in Gal- 
1 triggered T-cell death motivated the analysis of early membrane 
remodeling, an event determining the final signaling outcome, with 
a special focus on Lck redistribution in T-cells upon Gal-1 stim u­
lation, W e applied a co-culture system using Gal-1 non-producing 
(HeLamock) or Gal-1 transgenic (HeLaGal-1) HeLa cell lines as effector 
cells (for characterization see Supplementary Fig. 2, and Kovács­
Sólyom et al., 2010). As we showed earlier the ultimate requirement 
of HeLaGal-1 triggered T-cell apoptosis was the direct cell-cell con­
tact (Kovács-Sólyom et al., 2010).
T-cells and HeLa cells formed intimate cell-cell interaction 
within 15 min of co-culture, and as a result, the membrane asso­
ciated Gal-1 rapidly transferred from the surface of HeLaGal-1 to 
Jurkat cells (Fig. 1A right panel). Gal-1 was not detectable onJurkat 
co-cultured with HeLamock (Fig. 1A left panel). This result was in 
accordance to our previous finding (Kovács-Sólyom et al., 2010), 
and was reproducible when using another Gal-1 producing cell line, 
the C32 human melanoma (Supplementary Fig. 3). At early time 
point, 15 min of the cell-cell interaction, Gal-1 was mainly accu­
mulated in cell contact (Fig. 1A ) and then dispersed evenly on the 
cell surface of Jurkat (data not shown). Tight cell synapse between 
the tumor cell and T-cell, as detected by actin staining (Fig. 1B), 
generated different distribution of tyrosine kinase Lck depending 
on the absence or presence of Gal-1 in the effector cells: Lck clus­
tered to the cell synapse of Jurkat and HeLamock (Fig. 1B, upper 
panel) while it was sequestered to distal membrane site when 
Jurkat cells adhered to HeLaGal-1 (Fig. 1B, lower panel) after 60 min 
of co-culture. Localization of Lck to the opposite of the cell contact 
was significantly more frequent in cell-cell contact with HeLaGal-1 
than HeLamock cells (Fig. 1C and D), indicating the role of Gal-1 in 
this process. Plasma membrane distribution of Lck was uniform in 
untreated Jurkat cells (Supplementary Fig. 4). Lck appeared at the 
cell synaptic site when Jurkat cells were co-cultured with HeLamock 
and kept this position for up to 60 min (Fig. 1E). In contrast, a 
gradual, time dependent accumulation of Lck distal from the cell 
synapse was observed when HeLaGal-1 and Jurkat cells established 
cell contact. (Fig. 1E).
Specific role of Gal-1 in Lck membrane movement from cell 
synapse was examined in various experimental designs. First, 
HeLamock or lactose (competitor of galectins)-washed HeLamock 
induced Lck sequestration only in minor percentage of T-cells. 
In contrast, HeLamock cells covered with rGal-1induced high Lck 
sequestration (Fig. 1D lac HeLamock +rGal-1). Second, removal of 
surface Gal-1 from HeLaGal-1 with lactose (Fig. 1D lac HeLaGal-1) 
diminished the Lck exclusion from cell synapse. Lck sequestra­
tion was higher when induced by rGal-1 treated HeLamock than 
by transgenic HeLaGal-1 since surface Gal-1 amount was higher 
on HeLamock +rGal-1 than on HeLaGal-1 (Supplementary Fig. 2B 
and C). To rule out the effect of other galectins, all cell-surface P- 
galactoside binding lectins were removed from HeLamock (Fig. 1D 
lac HeLamock) surface with lactose, however, it had no effect com ­
pared to non-treated HeLamock indicating that the directed Lck 
membrane movement was not due to other types of galectins 
(Fig. 1D HeLamock vs. lac HeLamock). Moreover, analysis of gene 
expressions of Gal-1, Gal-3 (Supplementary Fig. 5) and other 
galectins, such as Gal-7 and -8 (data not shown) showed that 
HeLamock did not express none of these galectins while HeLaGal-1 
expressed only Gal-1.
The Gal-1 induced Lck sequestration was also detected when 
Jurkat cells were co-cultured with C32 melanoma (Supplementary 
Fig. 6), showing that other Gal-1 secreting cells are also capable 
to trigger this process. To ensure that the altered glycosylation in 
malignant T-cells (Ju et al., 2011) did not affect the examined cell
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Fig. 1. Cell-derived Gal-1 induced sequestration of Lck from cell synapse in Jurkat 
cells.Jurkat (J) cells were co-cultured with Gal-1 negative (HeLamock) or Gal-1 pro­
ducing tumor cells (HeLaGal-1) for different time points (15 min for A, 1 h for B-D, 
15-60min for E), and then the cells were fixed. (A) Cell surface bound Gal-1 was 
detected with anti-Gal-1-FITC in confocal microscope. (B and C) In permeabilized 
cells Lck and F-actin were labeled with FITC conjugated anti-Lck (green, B and C) and 
rhodamine-phalloidin (red, B) respectively, and detected with confocal (B) or fluo­
rescence microscopy (C). Arrows indicate the cell synapse. (D) Jurkat cells were in 
co-culture with HeLamock, lactose pre-treated HeLamock (lac Helamock), lactose pre­
treated HeLamock with recombinant Gal-1 bound (lac Helamock + rGal-1), HeLaGal-1 
or lactose pre-treated HeLaGal-1 (lac HelaGal-1) for 1 h. The cells were then fixed, 
permeabilized and labeled with mouse anti-Lck-FITC and analyzed in fluorescence 
microscope. The percentage of Jurkat cells with sequestered Lck was calculated as 
described inSection 2.4. The average and standard deviation was calculated from 3 to 
4 samples. Student’s t-test, **p <0.01, ***p <0.001. (E) The percentage ofJurkat cells 
with sequestered Lckwasdetermined foreachtime points(15-60 min) ofco-culture 
and results from 2 independent experiments were presented. (For interpretation of 
thereferencestocolorintext,thereaderisreferredtothewebversionofthisarticle.)
DIC Lck
Fig. 2. Cell-derived Gal-1 induced sequestration of Lck from cell synapse in PHA- 
activated human T-cells. PBMC were activated with PHA for 3 days (actT) and then 
co-cultured with HeLamock or HeLaGal-1 for 1 h. The cells werethen fixed, permeabili­
zed and labeled with mouse anti-Lck and anti-mouse IgG-NL557 (red) and analyzed 
with confocal microscope. Arrows indicate the cell synapse. Scale bar: 10 pm. The 
percentage ofT-cells with sequestered Lck was determined as described in Section 
2.4. The average and standard deviation was calculated from 4 samples. Student’s 
t-test, *p <0.05. (For interpretation of the references to color in text, the reader is 
referred to the web version of this article.)
B
D
Fig. 3. Activity of CD45 phosphatase was required for Lck sequestration. (A) CD45 
deficientJ45.01 cells were co-cultured with HeLaGal-1 or HeLamock for 1 h, then fixed 
and permeabilized. Lck was detected with mouse anti-Lck-FITC (green) by confocal 
microscopy. Scale bar: 10 pm. (B) Sequestration ofLck inJurkat and the CD45 defi­
cient J45.01 cells was compared in the co-culture with HeLaGal-1 or HeLamock for 1 h. 
The average and standard deviation ofthe percentage of cells with sequestered Lck 
was calculated from 4 samples oftwo independent experiments, and the subtraction 
ofthe values obtained in co-culture with HeLaGal-1 and HeLamock was presented, as 
described in Section 2.4. (C)Jurkat cells and PHA-activated T-cells were pre-treated 
with PTP CD45 inhibitor(10 pM for 20 min) and then co-cultured with HeLaGal-1 or 
HeLamock for 1 h. Sequestration ofLckwas determined from 4 samples oftwo inde­
pendent experiments asdescribed inprevious point.(D)Jurkat andJ45.01 cellswere 
co-cultured with HeLaGal-1 or HeLamock for 16h and then reacted with Annexin V- 
AlexaFluor488. Apoptosis was detected by fluorescent microscopy, and calculated 
as described inSection 2.5. Student’s t-test, *p <0.05, ***p< 0.001. (For interpretation 
of the references to color in text, the reader is referred to the web version of this 
article.)
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response, we verified our findings using human PHA-activated T- 
cells (actT). Similarly to Jurkat cells, significantly higher percentage 
of sequestered Lck was detected in actT when co-cultured with 
HeLaGal-1 as with HeLamock (Fig. 2). These results show that Gal-1 
plays critical role in the spatial regulation of Lck upon encounter of 
tumor cells and T-cells.
3.2. Involvement of CD45
The receptor tyrosine phosphatase, CD45 has been implicated as 
the main regulator of Lck activity and importantly it has been iden­
tified as a major Gal-1 binding protein (Pace et al., 1999; W alzel 
et al., 1999; Fouillit et al., 2000; Fajka-Boja et al., 2002). W hether 
CD45 plays a role in Gal-1 induced Lck segregation has been exam ­
ined. As Fig. 3 shows CD45 deficient variant ofJurkat, J45.01, readily 
attached to HeLa cells but did not respond with Lck sequestration, 
irrespectively of Gal-1 production by HeLa cells (Fig. 3A and B). This 
finding was further supported by using CD45 specific PTP inhibitor, 
since Lck segregation failed in the presence of the inhibitor either 
in Jurkat or actT-cells (Fig. 3C). Hence, both the presence and the 
phosphatase activity of CD45 were necessary in Gal-1 triggered Lck 
segregation. Effect of CD45 was not limited to Lck relocalization 
since J45.01 cells were unable to respond to HeLaGal-1 with apo­
ptosis (Fig. 3D ). These findings supported that the early membrane 
movements are important in the downstream cell death process.
3.3. Kinetics ofP-Tyr505 Lck exclusion from cell synapse
Kinase activity of Lck is negatively regulated by the tyrosine 
phosphorylation of its Tyr505 residue. Indeed, Lck species phos- 
phorylated on this particular tyrosine were excluded from the 
synaptic zone in a time dependent manner when Jurkat cells were 
co-cultured with HeLaCal-1 (Fig. 4A ). The localization and kinetics 
of sequestration of inactive P-Tyr505 Lck coincided with that of 
the total Lck pool (Fig. 4B and Fig. 1E, respectively). As expected, 
the signaling cascade initiated by Lck resulted in accumulation of 
tyrosine phosphorylated proteins in the synaptic zone (Fig. 4C and 
D). It has to be noted that HeLamock did not trigger specific m em ­
brane localization of Lck, P-Tyr505 Lck or tyrosine phosphorylated 
proteins (Fig. 4B and D).
3.4. GM1 ganglioside affects Gal-1 induced Lck segregation and 
apoptosis
One of the major Gal-1-binding cell surface glycoconjugates is 
the GM1 ganglioside (W ang et al., 2009; Fajka-Boja et al., 2008). 
Moreover, GM1 is a regular lipid component of rafts, which are 
the platform of signaling complexes (Tani-ichi et al., 2005). We 
verified the importance of raft formation in Gal-1-induced apo­
ptosis, since disrupting the integrity of membrane microdomains 
with P-cyclodextrin (P-CD), a cholesterol-chelator, inhibited the
Fig. 4. Tyrosine phosphorylation in response to Gal-1. Jurkat cells were co-cultured with HeLamock or HeLaGal-1 for different time points (15, 30, 45 or 60 min). (A and B) 
The cells were fixed and labeled with PE conjugated mouse anti-Lck P-Tyr505 (red) and FITC conjugated mouse anti-Lck (green), and analyzed with confocal microscopy. 
The average and standard deviation of the percentage of cells with sequestered Lck P-Tyr505 was calculated from two independent experiments, and the subtraction of 
the values obtained in co-culture with HeLaGal-1 and HeLamock was presented, as described in Section 2.4. (C and D) After the co-culture the cells were fixed, permeabilized 
and the tyrosine phosphorylated proteins were detected using 4G10 anti-phosphotyrosine mAb and anti-mouse IgG-NL557 (red). The average and standard deviation ofthe 
percentage of cells with tyrosine phosphorylated proteins accumulated in cell synapse was calculated from 4 independent experiments, and the subtraction of the values 
obtained in co-culture with HeLaGal-1 and HeLamock was presented, as described in Section 2.4. Arrows indicate the cell synapse after 45 min of co-culture (D). Scale bars: 
10 |xm. (For interpretation ofthe references to color in text, the reader is referred to the web version of this article.)
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apoptotic signal triggered by soluble Gal-1 in activated lym ­
phocytes (Ion et al., 2006). Therefore we analyzed whether raft 
formation and interaction between Gal-1 and GM1 ganglioside 
regulated the Gal-1-triggered Lck membrane localization and even­
tually T-cell apoptosis. As presented on Fig. 5A , GM1 accumulated 
at the contact site between tumor and T-cells while Lck migrated 
to the opposite. In the presence of P-CD both accumulation of GM1 
(Fig. 5A ) and segregation of Lck (Fig. 5A and B) failed either in 
Jurkat or activated T-cells (Fig. 5B), indicating that intact raft orga­
nization was crucial for this process. Since level of GM1ganglioside 
varies depending on the differentiation and activation state of the 
cells or in pathological situation (W ang et al., 2009), the question 
remains to be answered whether these changes affect the outcome 
of a signaling event. W e found that Jurkat and activated T-cells 
are heterogeneous for GM1 expression (Fig. 5C and Supplemen­
tary Fig. 7A). Jurkat and activated T-cells expressing low level of 
GM1 were enriched by magnetic bead selection (J.GM1|CI, Fig. 5C 
and actT GM 1lci Supplementary Fig. 7B) and co-cultured with HeLa 
cells. Segregation of Lck was significantly lower in J.G M 1 lci than in 
wild type Jurkat (Fig. 5D ). In parallel, sensitivity to Gal-1 induced 
apoptosis of GM1lo Jurkat and act T-cells were compared to unse­
lected Jurkat and GM 1hlgh act T-cells, respectively. Reduction of 
cell surface level of GM1 resulted in diminution of apoptosis as 
detected with Annexin V-binding assay or caspase-3 activation in 
Jurkat (Fig. 5E and F) or activated T-cells (Fig. 5E).
D E
sS «
Jurkat J.GM1'° actT actT 
GM1" GM1'°
Fig. 5. Gal-1 induced apoptosis was dependent on GM1 expression of T-cells. (A) 
Jurkat cells were co-cultured with Gal-1 positive C32 cells for 1 h in the absence 
(control, upper row) or presence (lower row) of 10 mM P-CD. GM1 was detected by 
FITC conjugated CTX (green), Lck was labeled with mouse anti-Lck and anti-mouse 
IgG-NL557 (red), and then analyzed with confocal microscopy. Scale bar: 10 |xm. 
(B) Jurkat cells or PHA-activated T-cells (actT) were co-cultured with HeLaGal-1 or 
HeLamock for 1 h in the presence or absence of P-CD. The percentage of cells with 
sequestered Lck was calculated from 5 (Jurkat) or 4 (T-cells) samples as described in 
Section 2.4. (C)The expression of GM1 on the cell surface was tested by flow cytom­
etry after CTX-FITC binding to Jurkat cells (black line) or J.GM1l° (gray line), the 
control was left untreated (dotted line). (D) J.GM1lo or Jurkat cells were co-cultured 
with HeLaGal-1 or HeLamock for 1 h, and then the sequestration of Lck was analyzed 
from 5 independent samples as described in Section 2.4. (E) Jurkat, J.GM1to, the 
GM1lc orGM1hi subsets of activated human T-cells were co-cultured with HeLaGal-1 
or HeLamock for 16 h and then reacted with Annexin V-AlexaFluor488. Apoptosis 
was detected by fluorescent microscopy, and calculated as described in Section 2.5.
4. Discussion
Apoptosis of T-lymphocytes is one of the hallmarks of the 
immunohomeostasis, including T-cell differentiation and down- 
regulation of effector functions. Among regulators ofT-cell viability, 
Gal-1, a P-galactoside binding lectin has been emerged. Signaling 
pathway inducing death of activated T-cells and T-cell lines by Gal- 
1 has recently been revealed (Hahn et al., 2004; Ion et al., 2006; 
Brandt et al., 2008). One of the most detailed description has been 
published in our laboratory (Ion et al., 2005, 2006; Kovács-Sólyom 
et al., 2010; Blaskó et al., 2011), however even this failed to explain 
the earliest membrane events in context of the eventual apoptosis. 
Here we show that intimate cell contact between Gal-1 produc­
ing effector cells and activated T- or Jurkat target cells results in 
T-cell apoptosis which requires the early lateral segregation of non­
receptor tyrosine kinase, Lck, a central component of Gal-1 induced 
cell death.
Previous report by Pace et al. suggested that reorganization of 
certain molecules within the membrane might be an important 
step during Gal-1 triggered T-cell apoptosis since Gal-1 binding 
induced spatial redistribution of its binding receptors into specific 
microdomains (Pace et al., 1999). In their model CD45 clustered 
with CD3 and CD7 co-localized in small membrane patches with 
CD43. The major limitation of this system has been the usage of sol­
uble recombinant human Gal-1 in high concentration (Pace et al., 
1999), a condition which does not occur physiologically. Therefore 
we applied cell-derived Gal-1 in co-culture system (Kovács-Sólyom 
et al., 2010) to ensure the natural presentation of Gal-1 and hence 
modeling the in vivo milieu. Moreover co-culture method avoided 
the disadvantages raising from using recombinant protein, such as 
requirement of reducing agent for maintaining functionality and 
affecting cell viability of Gal-1 (Stowell et al., 2007, 2008), and con­
troversial effects depending on the concentration of Gal-1 during
Student’s t-test, *p<0.05, ***p<0.001. (F) Jurkat orJ.GM1la were co-cultured with 
HeLaGal-1 for 16 (left panel) or 24 h (right panel) and apoptosis was detected with 
Annexin V-AlexaFluor488 (left panel) or rabbit anti-active caspase-3 and anti-rabbit 
Ig-FITC (right panel), then analyzed with fluorescent microscope. (For interpretation 
of the references to color in text, the reader is referred to the web version of this 
article.)
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the assays (Blaskó et al., 2011). It has to be noted that co-culture 
system has a disadvantage as well, namely that Gal-1 producing 
effector cells may express other galectins and unspecified factors 
which may affect the response of the target cells. Thus, the effects 
of the HeLamock (Gal-1 deficient), HeLamock covered with recombi­
nant Gal-1 and Gal-1 transgenic counterpart, HeLaGal-1 cells were 
compared. The results clearly confirmed the specific contribution of 
Gal-1 to Lck lateral movement and, as previously showed, to apo­
ptosis (Kovács-Sólyom et al., 2010), since Gal-1 treated HeLamock 
and HeLaGal-1 caused significantly higher Lck segregation and T-cell 
apoptosis than Gal-1 negative HeLamock. Moreover, the involve­
ment of other galectin family members was excluded with lactose 
competition and real time PCR.
Encounter of T-cells with Gal-1 in a tumor cell-bound form 
induced a conducted rearrangement of membrane components, 
in which the cell-contact site determined the topological rela­
tions. After 30 min of cell-cell interaction Lck translocated to distal 
pole of the contact and p-Tyr505 Lck, the inactive form of the 
enzyme, strongly co-localized with the whole Lck pool. In con­
trast tyrosine phosphorylated proteins increasingly accumulated 
within the contact site up to 30 min of the cell-cell contact, then 
tyrosine phosphorylation signal declined. Receptor tyrosine phos­
phatase, CD45 played critical role in this process since specific 
inhibition or deficiency of CD45 prevented Lck sequestration and 
following apoptosis. As CD45 is one of the major regulators of 
Lck function by activating its kinase activity with dephosphory- 
lating p-Tyr505 or maintaining Tyr 505 in dephosphorylated form 
(Sieh et al., 1993) it is conceivable that early activation of Lck 
within the cell contact zone is ensured by CD45. These results 
suggested the following serial of events: after interaction of effec­
tor Gal-1 presenting cells with T-cells, Lck promoted the tyrosine 
phosphorylation of signaling proteins accordingly our previous 
results (Ion et al., 2005, 2006; Kovács-Sólyom et al., 2010; Blaskó 
et al., 2011). After initiating the downstream processes, Lck left 
the signaling com plex and was expelled to the distal region of 
T-cell membrane in an inactivated form. Sequestration of Lck 
from the cell synapse was sustained up to several h (data not 
shown), and the cells underwent apoptosis accompanied by phos- 
phatidylserine externalization and caspase-3 activation. The role 
of CD45 is worth for some discussion. Early studies were con­
troversial in judging this question. First studies suggested that 
CD45 was the receptor for Gal-1 and it was indispensible in Gal- 
1 induced apoptosis (Perillo et al., 1995). However, further studies 
failed to prove that CD45 is the apoptosis-mediating receptor for 
Gal-1 (Fajka-Boja et al., 2002; Pace et al., 2000). Finally the anal­
ysis of CD45 glycosylation clarified its role in Gal-1’s cytotoxicity 
(Earl et al., 2010). It must be emphasized that all works, includ­
ing our previous ones, used soluble Gal-1. The results presented 
here support the theory that in the case when Gal-1 acts as a 
cell- or extracellular matrix coupled protein, the pathways and 
signaling components leading to the eventual T-cell death may 
differ in some aspects from that induced by soluble, recombinant 
Gal-1.
Directed movement of membrane associated molecules largely 
depends on lipid components within the membrane. One of the 
determining ingredients is GM1-ganglioside which does not only 
play a role in raft generation but also regulates signal transduc­
tion. Activated T-cells show enhanced GM1 expression (Tani-ichi 
et al., 2005; W ang et al., 2009) suggesting an increase of the stimu­
latory pathways. Lowering the level of glycosphingolipids by using 
glucosylceramide synthase inhibitor attenuates TCR signaling, T- 
cell proliferation and IL-2 production (Zhu et al., 2011 ). Our recent 
results show that the integrity of membrane microdomains is 
essential during Gal-1 triggered T-cell apoptosis (Kovács-Sólyom 
et al., 2010). Accordingly, the GM1 composition of the cell m em ­
brane plays also a crucial role in response to Gal-1: Lck segregation
is reduced and cells are less sensitive to Gal-1 induced apoptosis 
in T-cells with lower GM1 level compared to higher GM1 express­
ing T-cells. The importance of the GM1 level in T-cell membrane is 
also underscored by the observation that it is modified in patho­
logical situations, such as in T-cells of diabetic NOD mice (W u et al., 
2011) or systemic lupus erythematosus (SLE) (Jury et al., 2004). 
Moreover, the altered GM1 composition along with reduced level 
of TCR £-chain (Liossis et al., 1998) and Lck (Jury et al., 2003) leads 
to abnormal TCR signaling and dysfunction of SLE T-cells. Impor­
tantly, GM1 is a binding partner for Gal-1 (Kopitz et al., 1998; W ang 
et al., 2009), hence upon binding to Gal-1 it may participate in reg­
ulation of membrane movements ensuring the collection of extra- 
and intracellular components of the membrane proximal signaling 
factors.
The current theory emphasize the regulatory role of lattice 
between galectins and cell surface glycans (Rabinovich et al., 2007; 
Garner and Baum, 2008; Grigorian et al., 2009; Ledeen et al., 2012). 
In parallel, our results show robust spatial remodeling of intracellu­
lar signaling elements in inner membrane leaflet upon encounter 
of T-cells with Gal-1 producing effector cells. W hen Gal-1 is pre­
sented by the producer/effector cell or the extracellular matrix, it 
defines a spatial distribution of membrane proteins in target T-cells, 
leading to sequestering of Lck apart from the cell-cell contact site, 
and switching the downstream signaling pathway from immune 
response to apoptosis.
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